The shares of Emcure Pharmaceuticals jumped nearly 3 percent to hit a fresh record high on January 7, before erasing all gains to close in the red. An analyst has suggested which key levels investors ...

Zydus Lifesciences Ltd has announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates, has entered into a strategic partnership with Bioeq AG, a Swiss ...

The company has received multiple Letters of Award (LOAs) from Madhya Pradesh Urja Vikas Nigam (MPUVNL) for solar PV-based power plants (SPPs) for solar photovoltaic power-generating stations, with a ...

Emcure Pharmaceuticals on Monday said it saw Poviztra, its newly launched semaglutide brand, as a “long-term” opportunity in India’s fast-evolving obesity and cardiometabolic therapy market, even as ...

Emcure Pharmaceuticals Ltd. has announced the commercial launch of Poviztra, semaglutide injection, across India. With this launch Emcure becomes the first Indian company to exclusively distribute and ...

Vik Thapar, president – Corporate Development, Strategy and Finance at Emcure Pharmaceuticals, said the company considered deploying the molecule on its own but found the exclusive distribution ...

Emcure Pharmaceuticals announced the commercial launch of Poviztra, a semaglutide injection for chronic weight management, marking its entry into India’s fast-growing obesity and metabolic health ...

Emcure Pharmaceuticals Ltd. has announced the commercial launch of Poviztra, semaglutide injection, across India. With this launch Emcure becomes the first Indian company to exclusively distribute and ...

Drugmaker Emcure Pharmaceuticals has rolled out its Poviztra, the second brand of Novo Nordisk’s injectable Wegovy, at about 15-20 per cent less than the price of the innovator product, Emcure top ...

MUMBAI: Emcure Pharmaceuticals launched weight loss drug Poviztra on Monday under its exclusive partnership with Novo Nordisk. This marks the company’s entry into the fast-growing obesity segment in ...